Digital Therapeutics (DTx)

In this paper, Castor explores the benefits and challenges of Digital Therapeutics (DTx) trials and provides recommendations on best practices for data collection and management.

In this guide, Castor discusses routes to digital therapeutics commercialization and tools to meet the challenges on the path to market

The regulations around digital therapeutics (DTx) are constantly changing. Learn how DTx providers are trying to overcome these challenges

Download this whitepaper to gain a comprehensive overview of DTx, its regulatory landscape, and routes to commercialization.

This playbook is a tool for sponsors and CROs who want to leverage DCT technology to support remote interactions in their clinical studies.